Atlantic Coastal Acquisition Corp. II
Conduct an in vivo efficacy study in a xenograft mouse for ABP-102
Delivered after the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 22 Jan 2024
- Due
- 30 Jun 2024
- Delivered
- by 28 Apr 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“An in vivo efficacy study in a xenograft mouse is planned for the first half of 2024.”
What we found
Evidence strength A What the grades mean
Xenograft efficacy studies for ABP-102 were conducted and presented at conferences in 2025, after the first half of 2024 deadline.
-
A Atlantic Coastal Acquisition Corp. II - Form 8-K Original commitment stating xenograft efficacy study planned for first half of 2024.
-
C Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025 Reports in vivo xenograft study results including dual xenograft model efficacy data.
-
D Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025 First public presentation of xenograft efficacy study data at AACR 2025.
Checked 21 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Conduct
- Language
- Expected (“expects”, “plans”)
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesGemini (Google) re-read the evidence blind and read it as “no_evidence”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Atlantic Coastal Acquisition Corp. II? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-ABPWW-000025 · Corrections policy